These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11413094)

  • 21. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal management of acute coronary syndromes.
    Hillis LD; Lange RA
    N Engl J Med; 2009 May; 360(21):2237-40. PubMed ID: 19458369
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
    Gurm HS; Tamhane U; Meier P; Grossman PM; Chetcuti S; Bates ER
    Circ Cardiovasc Interv; 2009 Jun; 2(3):230-6. PubMed ID: 20031720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving acute coronary syndrome care: the ACC/AHA guidelines and critical pathways.
    Cannon C
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():22B-27B; discussion 27B-29B. PubMed ID: 12724583
    [No Abstract]   [Full Text] [Related]  

  • 26. [Update coronary artery disease: important progresses in acute and chronic therapy].
    Athanasiadis A; Sechtem U
    MMW Fortschr Med; 2012 Mar; 154(5):58-60. PubMed ID: 22624267
    [No Abstract]   [Full Text] [Related]  

  • 27. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.
    Antman EM; Hand M; Armstrong PW; Bates ER; Green LA; Halasyamani LK; Hochman JS; Krumholz HM; Lamas GA; Mullany CJ; Pearle DL; Sloan MA; Smith SC; ; Anbe DT; Kushner FG; Ornato JP; Jacobs AK; Adams CD; Anderson JL; Buller CE; Creager MA; Ettinger SM; Halperin JL; Hunt SA; Lytle BW; Nishimura R; Page RL; Riegel B; Tarkington LG; Yancy CW
    Circulation; 2008 Jan; 117(2):296-329. PubMed ID: 18071078
    [No Abstract]   [Full Text] [Related]  

  • 28. Will blocking the platelet save the diabetic?
    King SB; Mahmud E
    Circulation; 1999 Dec 21-28; 100(25):2466-8. PubMed ID: 10604881
    [No Abstract]   [Full Text] [Related]  

  • 29. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisions.
    Casterella PJ; Tcheng JE
    Am Heart J; 2008 May; 155(5):781-90. PubMed ID: 18440324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited.
    Tang WH; Lincoff AM
    Circulation; 2004 Dec; 110(24):3618-20. PubMed ID: 15596556
    [No Abstract]   [Full Text] [Related]  

  • 32. Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors.
    De Luca G; Gibson CM; Bellandi F; Noc M; Dudek D; Zeymer U; Arntz HR; Cutlip D; Maioli M; Zorman S; Mesquita Gabriel H; Emre A; Rakowski T; Gyongyosi M; Huber K; Van't Hof AW
    Atherosclerosis; 2009 Nov; 207(1):181-5. PubMed ID: 19426981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    Kushner FG; Hand M; Smith SC; King SB; Anderson JL; Antman EM; Bailey SR; Bates ER; Blankenship JC; Casey DE; Green LA; Hochman JS; Jacobs AK; Krumholz HM; Morrison DA; Ornato JP; Pearle DL; Peterson ED; Sloan MA; Whitlow PL; Williams DO;
    Circulation; 2009 Dec; 120(22):2271-306. PubMed ID: 19923169
    [No Abstract]   [Full Text] [Related]  

  • 34. Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction.
    Gum PA; Lincoff AM
    Int J Clin Pract; 2003; 57(1):43-8. PubMed ID: 12587942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.
    Marso SP; Lincoff AM; Ellis SG; Bhatt DL; Tanguay JF; Kleiman NS; Hammoud T; Booth JE; Sapp SK; Topol EJ
    Circulation; 1999 Dec 21-28; 100(25):2477-84. PubMed ID: 10604884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.
    Levine GN; Bates ER; Blankenship JC; Bailey SR; Bittl JA; Cercek B; Chambers CE; Ellis SG; Guyton RA; Hollenberg SM; Khot UN; Lange RA; Mauri L; Mehran R; Moussa ID; Mukherjee D; Nallamothu BK; Ting HH
    Circulation; 2011 Dec; 124(23):2574-609. PubMed ID: 22064598
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute coronary syndromes without ST-elevation -- treatment].
    Weber M; Hamm C
    Dtsch Med Wochenschr; 2003 Feb; 128(6):273-6. PubMed ID: 12571797
    [No Abstract]   [Full Text] [Related]  

  • 39. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
    Eagle KA; Berger PB; Calkins H; Chaitman BR; Ewy GA; Fleischmann KE; Fleisher LA; Froehlich JB; Gusberg RJ; Leppo JA; Ryan T; Schlant RC; Winters WL; Gibbons RJ; Antman EM; Alpert JS; Faxon DP; Fuster V; Gregoratos G; Jacobs AK; Hiratzka LF; Russell RO; Smith SC;
    Circulation; 2002 Mar; 105(10):1257-67. PubMed ID: 11889023
    [No Abstract]   [Full Text] [Related]  

  • 40. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
    Antman EM
    Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.